UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 1.105

Sortiert nach

041 Efficacy with continuous dosing, down-titration, or treatment withdrawal after successful treatment with baricitinib in patients with moderate-to-severe atopic dermatitis

Journal of investigative dermatology, 2021-10, Vol.141 (10), p.S155-S155

2021

Volltextzugriff (PDF)

106 Dupilumab treatment in patients with atopic hand and foot dermatitis: Results from a phase 3, randomized, double-blind, placebo-controlled trial

Journal of investigative dermatology, 2023-11, Vol.143 (11), p.S350

2023

Volltextzugriff (PDF)

IL-10R polymorphisms are associated with very-early-onset ulcerative colitis

Inflammatory bowel diseases, 2013-01, Vol.19 (1), p.115-123

2013

Volltextzugriff (PDF)

13-Year experience in external fixation of the pelvis: complications, reduction and removal

European journal of trauma and emergency surgery (Munich : 2007), 2016-02, Vol.42 (1), p.91-96

2016

Volltextzugriff (PDF)

14232 Basal cell carcinoma: An emerging epidemic in women in Iceland

Journal of the American Academy of Dermatology, 2020-12, Vol.83 (6), p.AB133-AB133

2020

Volltextzugriff (PDF)

164 What is the Incidence of Remediation in Emergency Medicine Residency Programs?

Annals of emergency medicine, 2014-10, Vol.64 (4), p.S60-S60

2014

Volltextzugriff (PDF)

176 Inpatient burden of dermatomyositis in united states adults

Journal of investigative dermatology, 2017-05, Vol.137 (5), p.S30-S30

2017

Volltextzugriff (PDF)

178 Effect of Dupilumab on Global Individual Signs Score Outcomes in Adults With Moderate-to-Severe Atopic Dermatitis: Combined Results From Four Phase 3 Trials

Journal of investigative dermatology, 2019-09, Vol.139 (9), p.S244-S244

2019

Volltextzugriff (PDF)

183 Raising the Bar on Treatment of Patients with Intellectual Disabilities in the Emergency Department

Annals of emergency medicine, 2020-10, Vol.76 (4), p.S70-S71

2020

Volltextzugriff (PDF)

188 Predictors of healthcare utilization in US adults with atopic dermatitis

Journal of investigative dermatology, 2019-05, Vol.139 (5), p.S33-S33

2019

Volltextzugriff (PDF)

HA-1A monoclonal antibody (centoxin) guidelines. Ad hoc Austin City-Wide Formulary Committee for Review of HA-1A

Hospital pharmacy (Philadelphia), 1991-10, Vol.26 (10), p.852

1991

Volltextzugriff (PDF)

204 A real-world study evaluating adeQUacy of Existing Systemic Treatments for patients with moderate-to-severe Atopic Dermatitis (AD-QUEST): Baseline treatment patterns and unmet needs assessment

Journal of investigative dermatology, 2017-05, Vol.137 (5), p.S35-S35

2017

Volltextzugriff (PDF)

234 Atopic dermatitis is associated with distinct phenotypes in US adults

Journal of investigative dermatology, 2019-05, Vol.139 (5), p.S40-S40

2019

Volltextzugriff (PDF)

245 Validation and interpretation of short form 12 and comparison with dermatology life quality index in adult atopic dermatitis

Journal of investigative dermatology, 2019-05, Vol.139 (5), p.S42-S42

2019

Volltextzugriff (PDF)

248 Patient and physician perspectives in atopic dermatitis: a population-based cross-sectional study

Journal of investigative dermatology, 2019-05, Vol.139 (5), p.S43-S43

2019

Volltextzugriff (PDF)

32824 Factors associated with treatment satisfaction in atopic dermatitis: A cross-sectional, population-based study examining patient and physician perspectives

Journal of the American Academy of Dermatology, 2022-09, Vol.87 (3), p.AB168-AB168

2022

Volltextzugriff (PDF)

373 Dupilumab improves clinical atopic dermatitis parameters and modulates specific IgEs and Staphylococcus aureus abundance

Journal of investigative dermatology, 2016-09, Vol.136 (9), p.S224-S224

2016

Volltextzugriff (PDF)

393 Comparative efficacy of targeted systemic therapies for moderate-to-severe atopic dermatitis without topical corticosteroids: an updated network meta-analysis

British journal of dermatology (1951), 2023-06, Vol.188 (Supplement_3)

2023

Volltextzugriff (PDF)

403 Achievement of minimal disease activity is associated with improvements in symptoms, quality of life and treatment satisfaction in patients with atopic dermatitis

British journal of dermatology (1951), 2023-06, Vol.188 (Supplement_3)

2023

Volltextzugriff (PDF)

43916 Efficacy and Safety of Abrocitinib and Dupilumab in Patients With Moderate-to-Severe Atopic Dermatitis in the Presence or Absence of Comorbid Asthma or Allergic Rhinitis: A Post Hoc Pooled Analysis of JADE COMPARE and JADE DARE

Journal of the American Academy of Dermatology, 2023-09, Vol.89 (3), p.AB156-AB156

2023

Volltextzugriff (PDF)

514 - Tapinarof cream 1% once daily: significant efficacy in the treatment of atopic dermatitis in two pivotal phase 3 trials in adults and children down to 2 years of age

British journal of dermatology (1951), 2024-02, Vol.190 (Supplement_2), p.ii17-ii18

2024

Volltextzugriff (PDF)

516 - Comparative efficacy of targeted systemic therapies with topical corticosteroids for moderate-to-severe atopic dermatitis: an updated network meta-analysis

British journal of dermatology (1951), 2024-02, Vol.190 (Supplement_2), p.ii19-ii20

2024

Volltextzugriff (PDF)

517 Effects of the oral janus kinase 1 (JAK1) inhibitor PF-04965842 on patient-reported outcomes (PROs) in adults with moderate to severe atopic dermatitis (AD)

Journal of investigative dermatology, 2018-05, Vol.138 (5), p.S88-S88

2018

Volltextzugriff (PDF)

526 - Efficacy of upadacitinib vs dupilumab for moderate-to-severe atopic dermatitis: analysis of time spent in itch response state from the Heads Up study

British journal of dermatology (1951), 2024-02, Vol.190 (Supplement_2), p.ii28-ii29

2024

Volltextzugriff (PDF)

1 – 25 von 1.105

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.052)
Mit Volltextzugriff
(932)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(1.094)
Japanisch
(124)
Französisch
(10)
Deutsch
(2)
Norwegisch
(2)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(9)

Menü

Weitere Dienste

Einstellungen

041 Efficacy with continuous dosing, down-titration, or treatment withdrawal after successful treatment with baricitinib in patients with moderate-to-severe atopic dermatitis

106 Dupilumab treatment in patients with atopic hand and foot dermatitis: Results from a phase 3, randomized, double-blind, placebo-controlled trial

IL-10R polymorphisms are associated with very-early-onset ulcerative colitis

13-Year experience in external fixation of the pelvis: complications, reduction and removal

14232 Basal cell carcinoma: An emerging epidemic in women in Iceland

164 What is the Incidence of Remediation in Emergency Medicine Residency Programs?

176 Inpatient burden of dermatomyositis in united states adults

178 Effect of Dupilumab on Global Individual Signs Score Outcomes in Adults With Moderate-to-Severe Atopic Dermatitis: Combined Results From Four Phase 3 Trials

183 Raising the Bar on Treatment of Patients with Intellectual Disabilities in the Emergency Department

188 Predictors of healthcare utilization in US adults with atopic dermatitis

HA-1A monoclonal antibody (centoxin) guidelines. Ad hoc Austin City-Wide Formulary Committee for Review of HA-1A

204 A real-world study evaluating adeQUacy of Existing Systemic Treatments for patients with moderate-to-severe Atopic Dermatitis (AD-QUEST): Baseline treatment patterns and unmet needs assessment

234 Atopic dermatitis is associated with distinct phenotypes in US adults

245 Validation and interpretation of short form 12 and comparison with dermatology life quality index in adult atopic dermatitis

248 Patient and physician perspectives in atopic dermatitis: a population-based cross-sectional study

259 Specific Crohn's Disease (CD) Associated Risk Alleles Are Associated With the Composition of the Intestinal Microbiota in Healthy First Degree Relatives (FDR) of CD Subjects

32824 Factors associated with treatment satisfaction in atopic dermatitis: A cross-sectional, population-based study examining patient and physician perspectives

373 Dupilumab improves clinical atopic dermatitis parameters and modulates specific IgEs and Staphylococcus aureus abundance

393 Comparative efficacy of targeted systemic therapies for moderate-to-severe atopic dermatitis without topical corticosteroids: an updated network meta-analysis

403 Achievement of minimal disease activity is associated with improvements in symptoms, quality of life and treatment satisfaction in patients with atopic dermatitis

43916 Efficacy and Safety of Abrocitinib and Dupilumab in Patients With Moderate-to-Severe Atopic Dermatitis in the Presence or Absence of Comorbid Asthma or Allergic Rhinitis: A Post Hoc Pooled Analysis of JADE COMPARE and JADE DARE

514 - Tapinarof cream 1% once daily: significant efficacy in the treatment of atopic dermatitis in two pivotal phase 3 trials in adults and children down to 2 years of age

516 - Comparative efficacy of targeted systemic therapies with topical corticosteroids for moderate-to-severe atopic dermatitis: an updated network meta-analysis

517 Effects of the oral janus kinase 1 (JAK1) inhibitor PF-04965842 on patient-reported outcomes (PROs) in adults with moderate to severe atopic dermatitis (AD)

526 - Efficacy of upadacitinib vs dupilumab for moderate-to-severe atopic dermatitis: analysis of time spent in itch response state from the Heads Up study

Suchergebnisse filtern